Ingredient · Evidence grade B-

Soy isoflavones & genistein for menopause: evidence, studies and safety

Last updated · 6 studies summarized

B- Short answer: Soy isoflavones (including genistein) are the most widely studied supplement group for occasional hot flashes associated with menopause*. Meta-analyses find modest average effects, such as about 20% fewer hot flashes than placebo in one analysis, and results vary between trials.

Key facts

Evidence gradeB- B- (modest effect, heterogeneous)
Use studiedhot flashes
Trialsdozens (Cochrane 2013 phytoestrogens: 43 RCTs; Taku 2012: 17 in MA)
Participants4,364 (Cochrane, all phytoestrogens); 6,653 (Franco 2016, 62 studies)
What reviews concludeTaku 2012: -20.6% frequency, -26.2% severity vs placebo; Franco JAMA 2016: -0.79 hot flashes/day; Cochrane 2013: no conclusive evidence, possible benefit at >30 mg genistein; NCCIH: effect may be small.
The Menopause Society (2023)Not recommended (Level II) – mixed evidence.
Also known assoy, isoflavones, genistein

Grades: A strong · B moderate · C limited · D none or negative. How we grade.

Every study we reviewed

Each summary gives who took part, the dose, how long, the result compared with placebo or control, and who paid for it.

  • Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.

    Newton KM, Reed SD, LaCroix AZ et al. · Ann Intern Med 2006 · Black cohosh, Soy isoflavones & genistein

    The US government-funded HALT study followed 351 women for a year. Black cohosh (160 mg a day), a 10-herb blend, and the blend plus more soy food did no better than a dummy pill for hot flashes, while hormone therapy clearly worked.

    Who
    351 women aged 45–55
    Dose
    black cohosh 160 mg/day; multibotanical; multibotanical + soy diet; hormone therapy; placebo
    Duration
    12 months
    Result
    No herbal arm differed from placebo at 3, 6 or 12 months (<1 hot flash/day difference); hormone therapy reduced ~4 symptoms/day vs placebo.
    Funding
    US NIH (NCCAM/NIA) – HALT study, independent. Independent / academic

    PubMed · Full text (DOI)

  • Phytoestrogens for menopausal vasomotor symptoms.

    Lethaby A, Marjoribanks J, Kronenberg F et al. · Cochrane Database Syst Rev 2013 · Red clover, Soy isoflavones & genistein

    An independent Cochrane review of 43 trials found no conclusive proof that phytoestrogens (soy, red clover) reduce hot flashes. High-genistein soy extracts looked more promising, and placebo effects were large.

    Who
    43 RCTs, 4,364 women
    Dose
    various phytoestrogens
    Duration
    various
    Result
    No conclusive evidence of reduced hot flushes; Promensil (red clover) not better than placebo (MD -0.93/day, NS); genistein >30 mg/day may help; strong placebo effect.
    Funding
    Cochrane review (independent). Independent / academic

    PubMed · Full text (DOI)

  • Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.

    Taku K, Melby MK, Kronenberg F et al. · Menopause 2012 · Soy isoflavones & genistein

    Pooling 17 trials, soy isoflavone supplements (about 54 mg a day) cut hot-flash frequency by about a fifth more than placebo. Products higher in genistein worked better. Results varied widely between studies.

    Who
    17 RCTs in meta-analysis
    Dose
    median 54 mg isoflavones/day
    Duration
    6 weeks–12 months
    Result
    Hot-flash frequency -20.6% and severity -26.2% vs placebo; >18.8 mg genistein about twice as effective.
    Funding
    Academic (Japan/US); funding not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.

    Franco OH, Chowdhury R, Troup J et al. · JAMA 2016 · Red clover, Soy isoflavones & genistein

    A JAMA analysis of 62 studies found plant estrogens such as soy cut about one hot flash a day compared with placebo – a modest effect – and most studies were of low quality.

    Who
    62 studies, 6,653 women
    Dose
    phytoestrogens and other plant therapies
    Duration
    various
    Result
    Phytoestrogens: -1.31 hot flashes/day; soy isoflavones -0.79/day; 74% of RCTs at high risk of bias.
    Funding
    Academic (Erasmus MC); industry co-funding reported in paper is not verified here. Industry-linked

    PubMed · Full text (DOI)

  • Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.

    Unfer V, Casini ML, Costabile L et al. · Fertil Steril 2004 · Soy isoflavones & genistein

    Italian women took high-dose soy isoflavones (150 mg a day) or placebo for 5 years. A small number on soy developed thickening of the womb lining (3.4% vs 0%), so long-term high doses deserve caution.

    Who
    376 women with intact uterus
    Dose
    soy isoflavones 150 mg/day
    Duration
    5 years
    Result
    Endometrial hyperplasia in 3.37% on soy vs 0% placebo; no cancers.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.

    Qiu S, Jiang C · Eur J Nutr 2019 · Soy isoflavones & genistein

    Studies following women with breast cancer found eating soy was linked to lower recurrence, not higher. These looked at soy food, not concentrated supplements.

    Who
    12 cohort studies, 37,275 breast-cancer patients
    Dose
    dietary soy/isoflavone intake
    Duration
    observational
    Result
    Pre- and post-diagnosis soy intake associated with lower recurrence; no harm signal.
    Funding
    Academic. Independent / academic

    PubMed · Full text (DOI)

Safety

Soy is a common allergen. In a 5-year trial of 150 mg/day isoflavones, endometrial hyperplasia occurred in 3.4% vs 0% on placebo (Unfer 2004). Cohort studies of soy foods in breast-cancer survivors link them with lower recurrence and show no harm signal, but the safety of concentrated isoflavone supplements after breast cancer is uncertain (NCCIH).

Ranked products that contain it

Ranked products containing Soy isoflavones & genistein, by our score.
ProductAmount per dayScore$/day
Centrum Menopause Support Complete Multivitamin + Hot Flash SupportGenistein: 30 mg75.4$0.67
The 'Pause Nutrition MenoMultiGenistein: 54 mg69.9$1.50
One A Day Women's Menopause FormulaSoybean isoflavones: 60 mg65.7$0.40
Estroven Menopause Relief + Weight ManagementSoy isoflavones: 56 mg58.4$0.63
Happy V Menopause Relief AM + PMGenistein from Sophora japonica: 40 mg48.9$2.00
AZO Menopause Relief Daytime GummiesGenistein: 30 mg48.6$0.68

FAQ

Does Soy isoflavones & genistein help with menopause symptoms?

Soy isoflavones (including genistein) are the most widely studied supplement group for occasional hot flashes associated with menopause*. Meta-analyses find modest average effects, such as about 20% fewer hot flashes than placebo in one analysis, and results vary between trials. Our evidence grade is B- (modest effect, heterogeneous). Taku 2012: -20.6% frequency, -26.2% severity vs placebo; Franco JAMA 2016: -0.79 hot flashes/day; Cochrane 2013: no conclusive evidence, possible benefit at >30 mg genistein; NCCIH: effect may be small.

Does The Menopause Society recommend Soy isoflavones & genistein?

Not recommended (Level II) – mixed evidence. The 2023 nonhormone statement recommends no dietary supplement for hot flashes; talk to a clinician about hormone therapy and prescription options.

Is Soy isoflavones & genistein safe?

Soy is a common allergen. In a 5-year trial of 150 mg/day isoflavones, endometrial hyperplasia occurred in 3.4% vs 0% on placebo (Unfer 2004). Cohort studies of soy foods in breast-cancer survivors link them with lower recurrence and show no harm signal, but the safety of concentrated isoflavone supplements after breast cancer is uncertain (NCCIH). Supplements are not FDA-approved before sale; ask a clinician or pharmacist, especially if you take medication.

Sources

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.